Jonathan Siegel is an accomplished professional in the field of biostatistics, currently serving as the Director of Clinical Statistics Oncology at Bayer Pharmaceuticals since August 2012. In this role, Jonathan oversees clinical development for three oncology compounds, including an antibody-drug conjugate and two immune checkpoint inhibitors, managing all aspects from clinical plan development to regulatory interactions. Previous positions include Deputy Director and Associate Director of Clinical Statistics Oncology, Principal Statistician at Everest Clinical Research Services Inc., and Senior Research Biostatistician at Bristol-Myers Squibb, where Jonathan contributed to significant Phase II and III studies. Jonathan's career also features founding a biostatistical consulting company and roles in statistical programming and research assistance early in the career. Jonathan earned a Master's degree in Statistics from Western Michigan University and a Bachelor's degree in Mathematics from the University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices